✦ LIBER ✦

OP-266: CARDIAC RESYNCHRONIZATION THERAPY IN OCTOGENARIANS: IS THERE ANY DIFFERENCE?

✍ Scribed by S. Okutucu; H. Aksoy; B. Evranos; C. Sabanov; N. Maharjan; L. Sahiner; E.B. Kaya; K. Aytemir; G. Kabakci; L. Tokgozoglu; H. Ozkutlu; A. Oto

Book ID: 117354168
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 49 KB
Volume: 147
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(11)70267-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is There a Gender Difference in Outcomes

Is There a Gender Difference in Outcomes of Cardiac Resynchronization Therapy?

✍ Kelly L. Brooke; Tracy Webster; David O. Hodge; Heather Wiste; David L. Hayes; Y 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 241 KB

59 Is There a Role for Cardiac Resynchro

59 Is There a Role for Cardiac Resynchronization Therapy in Pediatric Pulmonary Hypertension?

✍ K.S. Motonaga; C.Y. Miyake; R. Punn; D.N. Rosenthal; J.A. Feinstein; A.M. Dubin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 159 KB

There is no significant difference in th

There is no significant difference in the operative risk between octogenarians compared with patients younger than 60 years in cardiac surgery*

✍ H. Mächler; L. Salaymeh; B. Zirngast; M. Anelli-Monti; P. Oberwalder; A. Yates; 📂 Article 📅 2011 🏛 Blackwell Publishing 🌐 German ⚖ 102 KB

Incidence of ventricular arrhythmias in

Incidence of ventricular arrhythmias in patients with severe left ventricular systolic dysfunction: is there a benefit after cardiac resynchronization therapy?

✍ Ana Teresa Timóteo; Mário Martins Oliveira; Manuel Nogueira Silva; Alexandra Tos 📂 Article 📅 2011 🏛 Elsevier ⚖ 148 KB

There Is Plenty of Room for Cardiac Resy

There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure

✍ J. Claude Daubert; Christophe Leclercq; Philippe Mabo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 73 KB

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB